This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of acute transfusion reaction

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

management of acute transfusion reactions

Seek expert advice and check local guidelines.

Category 1: mild reactions

  • immediate management
    • slow the transfusion
    • administer antihistamine IM (e.g. chlorpheniramine 0.1 mg/kg or equivalent)
    • if no clinical improvement within 30 minutes or if signs and symptoms worsen, treat as Category 2 .

Category 2: moderately severe reactions

  • immediate management
    • stop the transfusion. Replace the infusion set and keep IV line open with normal saline
    • notify the doctor responsible for the patient and the blood bank immediately
    • send blood unit with infusion set, freshly collected urine and new blood samples (1 clotted and 1 anticoagulated) from vein opposite infusion site with appropriate request form to blood bank for laboratory investigations.
    • administer antihistamine IM (e.g. chlorpheniramine 0.1 mg/kg or equivalent) and oral or rectal antipyretic (e.g. paracetamol 10 mg/kg: 500 mg – 1 g in adults). Avoid aspirin in thrombocytopenic patients
    • give IV corticosteroids and bronchodilators if there are anaphylactoid features (e.g. broncospasm, stridor)
    • collect urine for next 24 hours for evidence of haemolysis and send to laboratory.
    • if clinical improvement, restart transfusion slowly with new blood unit and observe carefully
    • if no clinical improvement within 15 minutes or if signs and symptoms worsen, treat as Category 3

Category 3: life threatening reactions

  • immediate management
    • stop the transfusion. Replace the infusion set and keep IV line open with normal saline
    • infuse normal saline (initially 20–30 ml/kg) to maintain systolic BP. If hypotensive, give over 5 minutes and elevate patient’s legs
    • maintain airway and give high flow oxygen by mask.
    • give adrenaline (as 1:1000 solution) 0.01 mg/kg body weight by slow intramuscular injection
    • give IV corticosteroids and bronchodilators if there are anaphylactoid features (e.g. broncospasm, stridor).
    • give diuretic: e.g. frusemide 1 mg/kg IV or equivalent
    • send blood unit with infusion set, fresh urine sample and new blood samples (1 clotted and 1 anticoagulated) from vein opposite infusion site with appropriate request form to blood bank for investigations
    • check a fresh urine specimen visually for signs of haemoglobinuria
    • start a 24-hour urine collection and fluid balance chart and record all intake and output. Maintain fluid balance
    • assess for bleeding from puncture sites or wounds. If there is clinical or laboratory evidence of DIC , give platelets (adult: 5–6 units) and either cryoprecipitate (adult: 12 units) or fresh frozen plasma (adult: 3 units)
    • reassess. If hypotensive:
      • give further saline 20–30 ml/kg over 5 minutes
      • give inotrope, if available
    • if urine output falling or laboratory evidence of acute renal failure (rising K+, urea, creatinine):
      • maintain fluid balance accurately
      • give further frusemide
      • consider dopamine infusion, if available
      • seek expert help: the patient may need renal dialysis
    • if bacteraemia is suspected (rigors, fever, collapse, no evidence of a haemolytic reaction), start broad-spectrum antibiotics IV

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.